Skip to Main Content

Author Details

Aurelie Vogt
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
2012
20
12
PMIDPaper TitleJournal TitlePublished Year
36635305GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas.Sci Data2023
36635305GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas.Sci Data2023
36991516DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer.Clin Epigenetics2023
36991516DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer.Clin Epigenetics2023
35181301Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.J Invest Dermatol2022
35762214Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.Hum Mutat2022
35405740Examination of Genetic Susceptibility in Radiation-Associated Meningioma.Radiat Res2022
35181301Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.J Invest Dermatol2022
35405740Examination of Genetic Susceptibility in Radiation-Associated Meningioma.Radiat Res2022
35762214Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.Hum Mutat2022
34070849Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility.Cancers (Basel)2021
34070849Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility.Cancers (Basel)2021
32341527Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.Nat Genet2020
32004448Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia.Am J Hum Genet2020
32341527Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.Nat Genet2020
32637605XAF1 as a modifier of p53 function and cancer susceptibility.Sci Adv2020
33057211Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility.Sci Rep2020
32004448Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia.Am J Hum Genet2020
33057211Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility.Sci Rep2020
32637605XAF1 as a modifier of p53 function and cancer susceptibility.Sci Adv2020
31289279Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.Sci Rep2019
31289279Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.Sci Rep2019
29693246Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.Br J Haematol2018
29693246Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.Br J Haematol2018
29036293Rare germline variants in known melanoma susceptibility genes in familial melanoma.Hum Mol Genet2017
29036293Rare germline variants in known melanoma susceptibility genes in familial melanoma.Hum Mol Genet2017
29059430Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.J Natl Cancer Inst2017
29059430Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.J Natl Cancer Inst2017
27449771Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.Hum Genet2016
27449771Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.Hum Genet2016
25939664Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.Hum Genet2015
25896519Germline TP53 variants and susceptibility to osteosarcoma.J Natl Cancer Inst2015
25939664Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.Hum Genet2015
26084801A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.Cancer Discov2015
26459559Rare inactivating PDE11A variants associated with testicular germ cell tumors.Endocr Relat Cancer2015
26459559Rare inactivating PDE11A variants associated with testicular germ cell tumors.Endocr Relat Cancer2015
26084801A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.Cancer Discov2015
25896519Germline TP53 variants and susceptibility to osteosarcoma.J Natl Cancer Inst2015
22392686GSTM1 and GSTT1 copy numbers and mRNA expression in lung cancer.Mol Carcinog2012
22392686GSTM1 and GSTT1 copy numbers and mRNA expression in lung cancer.Mol Carcinog2012
  • 1 - 40 of 40

Recommended Authors

University of California san francisco
Career Start Year 2010
Number of shared co-authors 5
University of Oslo
Career Start Year 2007
Number of shared co-authors 0
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 3
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2006
Number of shared co-authors 9
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 14
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 10
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 6
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 1
University of California
Career Start Year 2003
Number of shared co-authors 0
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 9
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 3
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 7
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 14
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 10
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 11
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 19
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 4
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 2
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 7
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 10
University of Washington
Career Start Year 1996
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 11
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 24
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 23
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 14
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 21
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 25

Collaborators

Frederick National Laboratory for Cancer Research
Co-authored papers 15
National Cancer Institute, National Institutes of Health
Co-authored papers 14
Frederick National Laboratory for Cancer Research
Co-authored papers 13
National Cancer Institute
Co-authored papers 8
National Cancer Institute
Co-authored papers 7
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 5
Boston Children's Hospital and Harvard Medical School
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
Clinical Genetics Branch, National Cancer Institute
Co-authored papers 4
National Cancer Institute, National Institutes of Health, Inc.
Co-authored papers 4
National Cancer Institute, Frederick National Laboratory for Cancer Research
Co-authored papers 3
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
Clinica Universidad de Navarra
Co-authored papers 2
Co-authored papers 2
University of Navarra, Center for Applied Medical Research
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Co-authored papers 2
University of Toronto
Co-authored papers 2
University of Toronto
Co-authored papers 2
Keck School of Medicine of the University of Southern California
Co-authored papers 2
St Jude Children's Research Hospital
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2